Safety profile of belzutifan monotherapy in patients with renal cell carcinoma: A pooled analysis of 4 clinical trials

被引：3

作者：

Choueiri, Toni K. ^{[1
]}

Ghatalia, Pooja ^{[2
]}

de Velasco, Guillermo ^{[3
]}

Albiges, Laurence ^{[4
]}

Burotto, Mauricio ^{[5
]}

Suarez, Cristina ^{[6
]}

Brugarolas, James ^{[7
]}

Iacovelli, Roberto ^{[8
]}

Jalkanen, Katriina ^{[9
]}

Lam, Elaine T. ^{[10
]}

Srinivasan, Ramaprasad ^{[11
]}

Merchan, Jaime ^{[12
]}

Agarwal, Neeraj ^{[13
]}

Iversen, Ane B. ^{[14
]}

Rini, Brian ^{[15
]}

Bauer, Todd M. ^{[16
]}

Gurney, Howard ^{[17
]}

Iliopoulos, Othon ^{[18
,19
]}

Lin, Jianxin ^{[20
]}

Starkopf, Liis ^{[20
]}

Donica, Margarita ^{[20
]}

Gumieniak, Olga ^{[20
]}

Vickery, Donna ^{[20
]}

Liu, Yanfang ^{[20
]}

Perini, Rodolfo F. ^{[20
]}

Powles, Thomas ^{[21
]}

Jonasch, Eric ^{[22
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA USA

[2] Fox Chase Canc Ctr, Philadelphia, PA USA

[3] Univ Hosp 12 Octubre, Madrid, Spain

[4] Inst Gustave Roussy, Med Oncol Dept, Villejuif, France

[5] Bradford Hill Clin Res Ctr, Santiago, Chile

[6] Hosp Univ Vall Dhebron, Vall dHebron Inst Oncol VHIO, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain

[7] Univ Texas Southwestern Med Ctr Dallas, Internal Med Hematol Oncol, Dallas, TX USA

[8] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy

[9] HUS Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland

[10] Univ Colorado Anschutz Med Campus, Univ Colorado Canc Ctr, Aurora, CO USA

[11] NCI, Ctr Canc Res, Bethesda, MD USA

[12] Univ Miami Hosp & Clin, Sylvester Canc Ctr, Canc Res Serv, Oncol, Miami, FL USA

[13] Huntsman Canc Inst, Clin Translat Canc Res Genitourinary Oncol Progra, Salt Lake City, UT USA

[14] Aarhus Univ Hosp, Aarhus, Denmark

[15] Vanderbilt Ingram Canc Ctr, Nashville, OH USA

[16] Greco Hainsworth Ctr Res Tennessee Oncol PLLC, Nashville, TN USA

[17] Macquarie Univ, Oncol, Sydney, NSW, Australia

[18] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA

[19] Harvard Med Sch, Boston, MA USA

[20] Merck & Co Inc, Rahway, NJ USA

[21] Barts Hlth NHS Trust, St Bartholomews Hosp, London, England

[22] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

ONCOLOGIST | 2024年 / 29卷

关键词：

Belzutifan; HIF-2a; renal cell carcinoma;

D O I：

10.1093/oncolo/oyae181.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 50 条

[31] A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC).
Hutson, T. E.
Bukowski, R. M.
Rini, B. I.
Gore, M. E.
Larkin, J. M. G.
Figlin, R. A.
Barrios, C. H.
Escudier, B.
Lin, X.
Fly, K. D.
Martell, B.
Matczak, E.
Motzer, R. J.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[32] A pooled analysis of the efficacy and safety of cabozantinib post immunotherapy in patients with advanced renal cell carcinoma.
Oya, Mototsugu
Tamada, Satoshi
Tatsugami, Katsunori
Nakaigawa, Noboru
Osawa, Takahiro
Kanayama, Hiro-Omi
Kondoh, Chihiro
Sassa, Naoto
Nishimura, Kazuo
Nozawa, Masahiro
Masumori, Naoya
Miyoshi, Yasuhide
Kimura, Akiko
Kuroda, Shingo
Motzer, Robert J.
Choueiri, Toni K.
Tomita, Yoshihiko
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[33] FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma
Fallah, Jaleh
Heiss, Brian L.
Joeng, Hee-Koung
Weinstock, Chana
Gao, Xin
Pierce, William F.
Chukwurah, Benjamin
Bhatnagar, Vishal
Fiero, Mallorie H.
Amiri-Kordestani, Laleh
Pazdur, Richard
Kluetz, Paul G.
Suzman, Daniel L.
CLINICAL CANCER RESEARCH, 2024, 30 (22) : 5003 - 5008
[34] Retraction Note: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
Mototsugu Oya
Shuichi Kaneko
Tsuneo Imai
Toshiaki Tsujino
Toshiyuki Sunaya
Yutaka Okayama
Cancer Chemotherapy and Pharmacology, 2024, 93 : 523 - 523
[35] RETRACTED ARTICLE: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
Mototsugu Oya
Shuichi Kaneko
Tsuneo Imai
Toshiaki Tsujino
Toshiyuki Sunaya
Yutaka Okayama
Cancer Chemotherapy and Pharmacology, 2022, 89 : 761 - 772
[36] Safety and Tolerability of Eptinezumab in Patients With Migraine: A Pooled Analysis of 5 Clinical Trials
Smith, Timothy R.
Spierings, Egilius L. H.
Cady, Roger
Hirman, Joe
Schaeffler, Barbara
Shen, Vivienne
Sperling, Bjorn
Brevig, Thomas
Josiassen, Mette Krog
Brunner, Elizabeth
Mehta, Lahar
NEUROLOGY, 2021, 96 (15)
[37] Cardiac safety of lapatinib: Pooled analysis of 3689 patients enrolled in clinical trials
Perez, Edith A.
Koehler, Maria
Byrne, Julie
Preston, Alaknanda J.
Rappold, Erjca
Ewer, Michael S.
MAYO CLINIC PROCEEDINGS, 2008, 83 (06) : 679 - 686
[38] Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Timothy R. Smith
Egilius L. H. Spierings
Roger Cady
Joe Hirman
Barbara Schaeffler
Vivienne Shen
Bjørn Sperling
Thomas Brevig
Mette Krog Josiassen
Elizabeth Brunner
Loan Honeywell
Lahar Mehta
The Journal of Headache and Pain, 2021, 22
[39] Efficacy and Safety of Teriflunomide in Patients of Differing Ages: Analysis of Pooled Clinical Trials
Oh, Jiwon
Vukusic, Sandra
Tiel-Wilck, Klaus
Zaffaroni, Mauro
Cohan, Stanley
Inshasi, Jihad
Rog, David
Baker, Darren
Somera-Molina, Kathleen
Pyatkevich, Yelena
Poole, Elizabeth
Edwards, Keith
NEUROLOGY, 2019, 92 (15)
[40] Safety profile of abobotulinumtoxinA (Dysport®) for lower limb spasticity: Pooled analysis of controlled clinical trials
Tilton, Ann
Matthews, Dennis
Gormley, Mark
Suarez, Gustavo
Picaut, Philippe
Delgado, Mauricio
NEUROLOGY, 2018, 90

← 1 2 3 4 5 →